InvestorsHub Logo
Followers 2
Posts 2022
Boards Moderated 0
Alias Born 05/11/2017

Re: mypekeispooped post# 98848

Thursday, 05/16/2019 9:12:02 PM

Thursday, May 16, 2019 9:12:02 PM

Post# of 108192
Even though it’s apples to oranges, do you agree that the results are impressive? Very troubling that Advaxis had the data almost 4 years ago and we are still in square one. Iovance will be a leader in this area of the cervical cancer. As for the primary and the secondary outcome measures, Advaxis also had ORR. But it was not impressive and wasn’t pumped as the 12-months survival.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News